Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

The effect of long-term treatment with coenzyme Q10 on nucleic acid modifications by oxidation in children with Down syndrome

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Harvard

APA

CBE

MLA

Vancouver

Author

Larsen, Emil List ; Padella, Lucia ; Bergholdt, Helle Kirstine Mørup ; Henriksen, Trine ; Santoro, Lucia ; Gabrielli, Orazio ; Poulsen, Henrik Enghusen ; Littarru, Gian Paolo ; Orlando, Patrick ; Tiano, Luca. / The effect of long-term treatment with coenzyme Q10 on nucleic acid modifications by oxidation in children with Down syndrome. I: Neurobiology of Aging. 2018 ; Bind 67. s. 159-161.

Bibtex

@article{09b069e4d79d4871a9a0c0e3c3e76560,
title = "The effect of long-term treatment with coenzyme Q10 on nucleic acid modifications by oxidation in children with Down syndrome",
abstract = "Elevated levels of oxidative nucleic acid modifications have been proposed to be associated with some of the clinical characteristics of Down syndrome. Oral intake of coenzyme Q10 improves oxidative status and shows a tendency toward protective effect on DNA oxidation in certain age groups of children with Down syndrome. Here, we demonstrate that long-term (i.e., 4 years) treatment with coenzyme Q10 (ubiquinone) at the dosage of 4 mg/kg/d does not affect whole body DNA and RNA oxidation.",
keywords = "Journal Article",
author = "Larsen, {Emil List} and Lucia Padella and Bergholdt, {Helle Kirstine M{\o}rup} and Trine Henriksen and Lucia Santoro and Orazio Gabrielli and Poulsen, {Henrik Enghusen} and Littarru, {Gian Paolo} and Patrick Orlando and Luca Tiano",
note = "Copyright {\textcopyright} 2018 Elsevier Inc. All rights reserved.",
year = "2018",
month = jul,
doi = "10.1016/j.neurobiolaging.2018.03.001",
language = "English",
volume = "67",
pages = "159--161",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc",

}

RIS

TY - JOUR

T1 - The effect of long-term treatment with coenzyme Q10 on nucleic acid modifications by oxidation in children with Down syndrome

AU - Larsen, Emil List

AU - Padella, Lucia

AU - Bergholdt, Helle Kirstine Mørup

AU - Henriksen, Trine

AU - Santoro, Lucia

AU - Gabrielli, Orazio

AU - Poulsen, Henrik Enghusen

AU - Littarru, Gian Paolo

AU - Orlando, Patrick

AU - Tiano, Luca

N1 - Copyright © 2018 Elsevier Inc. All rights reserved.

PY - 2018/7

Y1 - 2018/7

N2 - Elevated levels of oxidative nucleic acid modifications have been proposed to be associated with some of the clinical characteristics of Down syndrome. Oral intake of coenzyme Q10 improves oxidative status and shows a tendency toward protective effect on DNA oxidation in certain age groups of children with Down syndrome. Here, we demonstrate that long-term (i.e., 4 years) treatment with coenzyme Q10 (ubiquinone) at the dosage of 4 mg/kg/d does not affect whole body DNA and RNA oxidation.

AB - Elevated levels of oxidative nucleic acid modifications have been proposed to be associated with some of the clinical characteristics of Down syndrome. Oral intake of coenzyme Q10 improves oxidative status and shows a tendency toward protective effect on DNA oxidation in certain age groups of children with Down syndrome. Here, we demonstrate that long-term (i.e., 4 years) treatment with coenzyme Q10 (ubiquinone) at the dosage of 4 mg/kg/d does not affect whole body DNA and RNA oxidation.

KW - Journal Article

U2 - 10.1016/j.neurobiolaging.2018.03.001

DO - 10.1016/j.neurobiolaging.2018.03.001

M3 - Journal article

C2 - 29665577

VL - 67

SP - 159

EP - 161

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

ER -

ID: 53711178